Pfizer Inc (PFE)

34.19
0.19 0.56
NYSE : Health Care
Prev Close 34.00
Open 33.74
Day Low/High 33.74 / 34.20
52 Wk Low/High 29.41 / 37.39
Volume 4.65M
Avg Volume 25.07M
Exchange NYSE
Shares Outstanding 5.96B
Market Cap 204.20B
EPS 1.20
P/E Ratio 29.31
Div & Yield 1.28 (3.70%)

Latest News

Trump, Ryan Spike Health Care Vote in Setback for President, GOP

Trump, Ryan Spike Health Care Vote in Setback for President, GOP

The vote on repealing and replacing Obamacare has been pulled from the House floor.

Closing Out Winning Pfizer Trade

There's no need to take any risks here amid the health-care vote.

Pfizer Receives Positive CHMP Opinion For TRUMENBA® For Prevention Of Meningococcal Group B Disease

Pfizer Receives Positive CHMP Opinion For TRUMENBA® For Prevention Of Meningococcal Group B Disease

Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that TRUMENBA ® (Meningococcal Group B...

Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment

Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment

Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.

Pfizer Invites Public To View And Listen To Webcast Of May 2 Conference Call With Analysts

Pfizer Invites Public To View And Listen To Webcast Of May 2 Conference Call With Analysts

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

Obamacare? Trumpcare? These stocks don't care.

These 4 Healthcare Charts Are Signaling Buys

These 4 Healthcare Charts Are Signaling Buys

Here's a rundown of four technical setups that are showing solid trading potential.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired former U.S. Attorney Preet Bharara was investigating stock trades made by Health and Human Services Secretary Tom Price, according to one report.

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Investor sentiment soured on Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

Stocks are slightly lower by early afternoon Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

Stocks Extend Declines as Biogen Leads Health Care Selloff

Stocks Extend Declines as Biogen Leads Health Care Selloff

Early morning gains quickly evaporate on Thursday as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.

Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its oral Janus kinase (JAK) inhibitor, XELJANZ ® (tofacitinib citrate), in China for the...

AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results

AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results

AstraZeneca's PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo.

Pfizer Launches Zavicefta™ (ceftazidime-avibactam) In The U.K. And Germany, A New Antibiotic To Treat Complicated Infections Caused By Gram-Negative Bacteria

Pfizer Launches Zavicefta™ (ceftazidime-avibactam) In The U.K. And Germany, A New Antibiotic To Treat Complicated Infections Caused By Gram-Negative Bacteria

Pfizer Inc. today announced that Zavicefta , a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring hospitalization, is now available...

The 10 Most Important Tips for Playing the Stock Market in March

The 10 Most Important Tips for Playing the Stock Market in March

Where should you put your money in March? TheStreet has the strategies and analysis to help guide your investment moves for the month.

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

While it's not a surprise that Global Blood is a takeout target, the timing of Novo Nordisk's interest in the company comes as a surprise, according to a stock analyst.

Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare

Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare

The Democrats aim to generate public opposition to repeal by offering amendments that highlight fears the GOP plan will result in more expensive insurance and fewer people with coverage.

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer, at the Barclays Global Healthcare...

State Street Calls for More Women on Boards

State Street Calls for More Women on Boards

In light of International Women's Day, State Street Global Advisors is pushing companies to put more women on boards, and preparing for proxy battles for companies that don't.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

Stocks Fall for Day Two as Trump Targets Health Care Sector

Stocks Fall for Day Two as Trump Targets Health Care Sector

Stocks fall for a second day on Tuesday, the first back-to-back decline since January, as a selloff in health care spoils attempts by the market to push higher.

Stocks Slide as Health Care Sector Weighs on Wall Street

Stocks Slide as Health Care Sector Weighs on Wall Street

Stocks slump Tuesday as a selloff in health care spoils an attempt by the market to push higher.

Cramer: When a Trump Tweet Is a Buy Signal

Cramer: When a Trump Tweet Is a Buy Signal

Drug companies are the latest targets/beneficiaries.

Trump's Tax Plans: Biggest Winners and Losers

Trump's Tax Plans: Biggest Winners and Losers

Among President Trump's many sweeping proposals, corporate tax reform stands the greatest chance of success. Here's how to trade.